September 2019 Issue

GO TO FULL ISSUE

Get Enterprise-wide Access

Med Updates

Evenity
romosozumab
A sclerostin inhibitor for treatment of postmenopausal osteoporosis in women at high risk for fracture

Onstryv
safinamide
An MAO-B inhibitor add-on therapy for "off" Parkinson's episodes in patients on stable doses of levodopa

Skyrizi
risankizumab
An interleukin-23 antagonist for moderate to severe plaque psoriasis

More Med Updates